Admission Inquiry

Dr. Aanchal Verma

Dr. Aanchal Verma

  • Assistant Professor
    Institute of Pharmaceutical Research
  • Department

    Pharmaceutical Research
  • Contact Details:

    Email :

    Contact Number :

  • Qualifications

    • PhD from GLA University, Mathura, 2025
    • M. Pharm (Pharmacology) from GLA University, Mathura, 2021
    • B. Pharm from Banasthali University, Rajasthan, 2019

Research Articles:

  • Verma, A., & Goyal, A. (2025). Glucagon-like Peptide-1 Boosts Plumbagin's Neuroprotection Against Rotenone-Induced Motor Deficits. Current Protein & Peptide Science. Advance online publication.
    Impact Factor- 2; Publisher- Bentham Science; Indexing- SCI Expanded
  • Verma, A., & Goyal, A. (2025). Plumbagin's Healing Effect on Motor Impairment in Rotenone-toxified Rodents. Current Neurovascular Research, 21(4), 434–446.
    Impact Factor- 2; Indexing- SCI Expanded
  • Verma, A., & Goyal, A. (2022). Reformative effect of daidzein on motor dysfunction following rotenone injection in ovariectomized rats. Revista Brasileira de Farmacognosia Impact Factor- 1.6; Indexing- SCI Expanded

Review Articles:

  • Goyal, A., Kumari, A., Verma, A., Kumar, R., Thakur, M., & Gopika, S. (2025). From Nature to Neuroscience: Exploring Carvacrol's Therapeutic Potential in Brain Health. Central Nervous System Agents in Medicinal Chemistry. Advance online publication.
    Journal Details- Print ISSN: 1871-5249 Online ISSN: 1875-6166
    Impact Factor- 2.6; Publisher- Bentham Science; Indexing- SCI Expanded
  • Goyal, A., Kumari, A., Verma, A., & Agrawal, N. (2025). Rapamycin and Autophagy: Potential Therapeutic Approach for Parkinson's Disease Treatment. CNS & Neurological Disorders Drug Targets. Advance online publication.
    Impact Factor- 3; Publisher- Bentham Science; Indexing- SCI Expanded
  • Goyal, A., Kumari, A., Verma, A., Bhatiya, S., & Yadav, H. N. (2025). Cannabinoid Receptor 1: The Neural Gatekeeper of Health and Disease. Current Neurovascular Research. Advance online publication.
    Impact Factor- 2; Publisher- Bentham Science; Indexing- SCI Expanded
  • Dubey, N., Vishwakarma, V. K., Verma, A., Goyal, A., & Yadav, H. N. (2025). The Role of EPAC in the Pathogenesis of Cardiovascular Complications: A Review. Indian Journal of Pharmaceutical Education & Research, 60 (Online First): 1–10.
    Impact Factor- 0.8; Indexing- SCI Expanded
  • Dubey, N., Vishwakarma, V. K., Verma, A., Goyal, A., Yadav, H. N., Reeta, K. H., Yadav, S. C., & Parakh, N. (2025). Cardiac Fibroblast Receptors: A Preclinical Dive into Their Regulatory Influence on Cardiovascular Diseases. Journal of Biochemical & Molecular Toxicology, 39(6), e70347.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Dubey, N., Verma, A., Goyal, A., Vishwakarma, V., Bhatiya, J., Arya, D. S., & Yadav, H. N. (2025). The Role of Endothelin and its Receptors in Cardiomyopathy: From Molecular Mechanisms to Therapeutic Insights. Pathology, Research & Practice, 269, 155932.
    Impact Factor- 2.9; Indexing- SCI Expanded
  • Goyal, A., Kumari, A., Verma, A., Chaudhary, V., Pathak, P., & Yadav, H. N. (2025). Nature's Neuroprotector: Honokiol and its Promise for Alzheimer's and Parkinson's. Brain Disorders, 17, 100208.
    Impact Factor- 1.9; Indexing- SCI Expanded
  • Goyal, A., Kumari, A., Verma, A., Chaudhary, V., Agrawal, V., & Yadav, H. N. (2024). Silent Information Regulator 1/Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Axis: A Promising Target for Parkinson's and Alzheimer's Disease Therapies. Journal of Biochemical & Molecular Toxicology, 38(12), e70078.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Goyal, A., Sikarwar, O., Verma, A., Solanki, K., & Mishra, M. K. (2024). Therapeutic Overview of Sudachitin. Journal of Biochemical & Molecular Toxicology, 38(11), e70003.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Goyal, A., Kumari, A., Solanki, K., Verma, A., & Agrawal, N. (2024). Exploring the Healing Powers of Saikosaponin A: A Review of Current Perspectives. Pharmacological Research–Modern Chinese Medicine, 100500.
    Indexing- SCOPUS
  • Verma, A., & Goyal, A. (2024). Beyond Insulin: The Intriguing Role of GLP-1 in Parkinson's Disease. European Journal of Pharmacology, 982, 176936.
    Impact Factor- 4.2; Indexing- SCI Expanded
  • Goyal, A., Agrawal, N., Agrawal, N., Verma, A., Solanki, K., & Yadav, H. N. (2024). The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer's and Parkinson's Treatment. Combinatorial Chemistry & High Throughput Screening. Advance online publication.
    Impact Factor- 1.6; Indexing- SCI Expanded
  • Goyal, A., Singh, V. D., Solanki, K., & Verma, A. (2024). Revealing the Curative Possibilities: A Comprehensive Exploration of Caffeic Acid. Current Pharmaceutical Biotechnology, 26(9), 1303–1313.
    Impact Factor- 2.2; Indexing- SCI Expanded
  • Goyal, A., Sikarwar, O., Verma, A., Solanki, K., Agrawal, N., Dubey, N., & Yadav, H. N. (2024). Unveiling Myricetin's Pharmacological Potency: A Comprehensive Exploration of the Molecular Pathways. Journal of Biochemical & Molecular Toxicology, 38(6), e23739.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Goyal, A., Solanki, K., & Verma, A. (2024). Luteolin: Nature's Promising Warrior Against Alzheimer's and Parkinson's Disease. Journal of Biochemical & Molecular Toxicology, 38(1), e23619.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Goyal, A., Dubey, N., Agrawal, A., Sharma, R., & Verma, A. (2024). An Insight into the Promising Therapeutic Potential of Chicoric Acid. Current Pharmaceutical Biotechnology, 25(13), 1708–1718.
    Impact Factor- 2.2; Indexing- SCI Expanded
  • Verma, A., Chaudhary, S., Solanki, K., Goyal, A., & Yadav, H. N. (2024). Exendin-4: A Potential Therapeutic Strategy for Alzheimer's Disease and Parkinson's Disease. Chemical Biology & Drug Design, 103(1), e14426.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Verma, A., Dubey, N., Agrawal, A., & Goyal, A. (2023). Dietary, Herbal and Nutritional Interventions for Managing Rheumatoid Arthritis: A Review. Current Pharmaceutical Biotechnology. Advance online publication.
    Impact Factor- 2.2; Indexing- SCI Expanded
  • Verma, A., & Goyal, A. (2023). Unravelling the Potent Anti-Oxidant and Anti-Inflammatory Actions of Plumbagin: A Review of Preclinical Discoveries. Pharmacological Research–Modern Chinese Medicine, 100351.
    Indexing- SCOPUS
  • Goyal, A., Dubey, N., Verma, A., & Agrawal, A. (2023). Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases. Current Molecular Medicine, 24(4), 419–427.
    Impact Factor- 2.2; Indexing- SCI Expanded
  • Goyal, A., Dubey, N., Agrawal, A., Verma, A., & Sharma, R. (2023). Therapeutic Potential of Morin. Pharmacological Research–Modern Chinese Medicine, 9, 100318.
    Indexing- SCOPUS
  • Verma, A., Kumari, K., Varshney, P., & Goyal, A. (2023). Pharmacological Actions of Tanshinone IIA with Special Focus on Nrf-2 Signaling Pathway. Revista Brasileira de Farmacognosia, 33(5), 924–935.
    Impact Factor- 1.4; Indexing- SCI Expanded
  • Goyal, A., Agrawal, A., Dubey, N., & Verma, A. (2023). High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease. Current Pharmaceutical Biotechnology, 25(8), 937–943.
    Impact Factor- 2.2; Indexing- SCI Expanded
  • Goyal, A., Chisti, W., Verma, A., Agrawal, N., & Bansal, K. (2023). The Role of Serotonergic System of the Brain in the Pathogenesis of Parkinson’s Disease. Neurochemical Journal, 17, 30–41.
    Impact Factor- 0.5; Indexing- SCI Expanded
  • Goyal, A., Kumari, R., Verma, A., Dubey, N., & Agrawal, A. (2023). Matrix Metalloproteinase-9 and its Involvement in Parkinson’s Disease. Neurochemical Journal, 17, 236–242.
    Impact Factor- 0.5; Indexing- SCI Expanded
  • Goyal, A., Verma, A., Agrawal, A., Dubey, N., Kumar, A., & Behl, T. (2023). Therapeutic Implications of Crocin in Parkinson's Disease: A Review of Preclinical Research. Chemical Biology & Drug Design, 101(6), 1229–1240.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Goyal, A., Agrawal, A., Verma, A., & Dubey, N. (2023). The PI3K-AKT Pathway: A Plausible Therapeutic Target in Parkinson's Disease. Experimental & Molecular Pathology, 129, 104846.
    Impact Factor- 3.2; Indexing- SCI Expanded
  • Goyal, A., Verma, A., Agrawal, N., & Pathak, S. (2023). Ayurvedic Herbs and Spices: A Promising Approach for the Treatment of Covid-19. The Natural Products Journal, 13(3), e200522205091.
    Indexing- SCOPUS
  • Goyal, A., Singh, G., & Verma, A. (2023). A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders. CNS & Neurological Disorders Drug Targets, 22(6), 789–800.
    Impact Factor- 3; Indexing- SCI Expanded
  • Goyal, A., Solanki, A., & Verma, A. (2023). Preclinical Evidence-based Review on Therapeutic Potential of Eugenol for the Treatment of Brain Disorders. Current Molecular Medicine, 23(5), 390–400.
    Impact Factor- 2.2; Indexing- SCI Expanded
  • Goyal, A., Agrawal, A., Verma, A., & Dubey, N. (2023). Therapeutic Implications of Crocin in Parkinson’s Disease. Chemical Biology & Drug Design.
    Indexing- SCI Expanded
  • Goyal, A., Verma, A., Dubey, N., Raghav, J., & Agrawal, A. (2022). Naringenin: A Prospective Therapeutic Agent for Alzheimer's and Parkinson's Disease. Journal of Food Biochemistry, 46(12), e14415.
    Impact Factor- 3.5; Indexing- SCI Expanded
  • Verma, A., & Goyal, A. (2022). Phytochemical-Based Therapeutic Strategies for Neurodegenerative Disorders. Current Neurovascular Research.
    Indexing- SCI Expanded

Paper presented in International / National Conferences:

  • Aanchal Verma, Ahsas Goyal, “GLP-1 mediates the neuroprotective effects of plumbagin in countering rotenone-induced motor dysfunction”, presented at National Conference on Advances in Biological Sciences: Molecules to Organisms, held on 28–29 December 2024, organized by the Department of Zoology, Aligarh Muslim University, Aligarh, India.
  • Aanchal Verma, Ahsas Goyal, “The restorative impact of plumbagin on motor dysfunction in rodents exposed to rotenone toxicity”, presented at International Pharmacology Conference & 54th Annual Conference of Indian Pharmacological Society (IPC-IPSCON 2024), held on 28–30 November 2024, organized by the Department of Pharmacology, AIIMS, New Delhi, India.
  • Aanchal Verma, Ahsas Goyal, “GLP-1: A New Frontier in Parkinson’s Research”, presented at International Conference on Innovations in Chemical, Biological and Pharmaceutical Sciences (ICBPS-2024), held on 4–5 October 2024, organized by the Institute of Pharmaceutical Research, GLA University, Mathura, India.
  • Aanchal Verma, Ahsas Goyal, “Unravelling the Potent Anti-oxidant and Anti-inflammatory Actions of Plumbagin”, presented at International Conference on Innovations in Chemical, Biological and Pharmaceutical Sciences (ICBPS-2023), held on 23–25 November 2023, organized by the Institute of Pharmaceutical Research, GLA University, Mathura, India.
  • Aanchal Verma, Ahsas Goyal, “The Role of Nrf-2 Signaling Pathway in the Pharmacological Actions of Tanshinone IIA”, presented at International Conference on Innovations in Chemical, Biological and Pharmaceutical Sciences (ICBPS-2022), held on 18–19 November 2022, organized by the Institute of Pharmaceutical Research, GLA University, Mathura, India.
  • Aanchal Verma, “Protective Role of Chlorogenic Acid in Neurodegeneration: A Focus on Alzheimer’s Disease”, presented at One-Day National Symposium on Challenges and Opportunities in the Management of Neurological Disorders, held on 7 December 2022, organized by the Department of Pharmacology and Toxicology, NIPER Guwahati, India.
  • Aanchal Verma, Ahsas Goyal, “Evaluation of Estrogen Agonist Daidzein on Motor Disorders in an Ovariectomized Animal Model of Parkinsonism”, presented at International Conference on Innovations in Chemical, Biological and Pharmaceutical Sciences (ICBPS-2021), held on 26–27 November 2022, organized by the Institute of Pharmaceutical Research, GLA University, Mathura, India.
  • Aanchal Verma, Ahsas Goyal, Neetu Agrawal, “Role of Phytoestrogens in Parkinson’s Disease”, presented at Society for Neurochemistry India – 34th SNCI Annual Conference (Virtual) on “Brain Diseases, Injuries and Infections: Emerging Challenges and Treatment Strategies”, held on 11–13 December 2020, at the University of Hyderabad, Telangana, India.

International / National Conference Attended

  • Attended International Conference on “Advances in Pharmaceutical and Health Sciences” on 7-8 Oct 2021 organized by KIET School of Pharmacy & CSIR-Indian Institute of Toxicological Research, Lucknow, India.

Workshop Attended

  • Attended hands on training program on “Molecular Docking and Molecular Dynamics Simulation” 25-26 Sept 2023 organized by Institute of Pharmaceutical Research, GLA University, Mathura, India.
Admission Helpline 9027068068